Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ <sub>1–42</sub> -induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease
Mehdi Alami(Université de Sherbrooke), Hicham Berrougui(Université de Sherbrooke), Charles Ramassamy(Institut National de la Recherche Scientifique), Olaf van Tellingen(Dutch Cancer Society), Alan A. Cohen(Université de Sherbrooke), Tamàs Fülöp(Université de Sherbrooke), Ton Bunt(Izumi Biosciences), Nabil Hajji(Cancer Research Center), Jacek M. Witkowski(Gdańsk Medical University), Abdelouahed Khalil(Université de Sherbrooke), Denis Gris(Université de Sherbrooke), Benoît Laurent(Université de Sherbrooke), Guy Lacombe(Université de Sherbrooke), Katsuiku Hirokawa(Nitobe Memorial Nakano General Hospital), Echarki Zerif(Université de Sherbrooke)
Cited by 12
Related Papers
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
|Nature Immunology|2011|1.8k
Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?
|Frontiers in Immunology|2018|1.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941